Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Rocuronium for Video Laryngoscopy-assisted Tracheal Intubation
NCT06564857Phase 4Recruiting
- Sponsor
- Nordsjællands Hospital
- Start
- Nov 2025
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil (2 arms), sponsored by Nordsjællands Hospital. Primary endpoints: Proportion of participants with one or more intubation or anaesthesia related adverse events and Proportion of participants with failed first-pass intubation at 2 minutes. Started Nov 2025; status: recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT06564857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06564857.